These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 9703523)

  • 1. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.
    van Beek I; Dwyer R; Dore GJ; Luo K; Kaldor JM
    BMJ; 1998 Aug; 317(7156):433-7. PubMed ID: 9703523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hepatitis C virus infection among injecting drug users in Sydney.
    van Beek I; Buckley R; Stewart M; MacDonald M; Kaldor J
    Genitourin Med; 1994 Oct; 70(5):321-4. PubMed ID: 8001943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
    Patrick DM; Tyndall MW; Cornelisse PG; Li K; Sherlock CH; Rekart ML; Strathdee SA; Currie SL; Schechter MT; O'Shaughnessy MV
    CMAJ; 2001 Oct; 165(7):889-95. PubMed ID: 11599327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.
    Bodsworth NJ; Cunningham P; Kaldor J; Donovan B
    Genitourin Med; 1996 Apr; 72(2):118-22. PubMed ID: 8698359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus incidence among injecting drug users on opioid replacement therapy.
    Hallinan R; Byrne A; Amin J; Dore GJ
    Aust N Z J Public Health; 2004 Dec; 28(6):576-8. PubMed ID: 15707209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High hepatitis C incidence in new injecting drug users: a policy failure?
    Maher L; Li J; Jalaludin B; Chant KG; Kaldor JM
    Aust N Z J Public Health; 2007 Feb; 31(1):30-5. PubMed ID: 17333606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users.
    van den Berg CH; Smit C; Bakker M; Geskus RB; Berkhout B; Jurriaans S; Coutinho RA; Wolthers KC; Prins M
    Eur J Epidemiol; 2007; 22(3):183-93. PubMed ID: 17334821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?
    Taylor A; Goldberg D; Hutchinson S; Cameron S; Gore SM; McMenamin J; Green S; Pithie A; Fox R
    J Infect; 2000 Mar; 40(2):176-83. PubMed ID: 10841096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative incidence of hepatitis C seroconversion in a cohort of seronegative injecting drug users.
    Brunton C; Kemp R; Raynel P; Harte D; Baker M
    N Z Med J; 2000 Mar; 113(1106):98-101. PubMed ID: 10836310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users.
    Levine OS; Vlahov D; Brookmeyer R; Cohn S; Nelson KE
    J Infect Dis; 1996 Mar; 173(3):579-83. PubMed ID: 8627020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France.
    Lucidarme D; Bruandet A; Ilef D; Harbonnier J; Jacob C; Decoster A; Delamare C; Cyran C; Van Hoenacker AF; Frémaux D; Josse P; Emmanuelli J; Le Strat Y; Desenclos JC; Filoche B
    Epidemiol Infect; 2004 Aug; 132(4):699-708. PubMed ID: 15310172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spread of bloodborne viruses among Australian prison entrants.
    Crofts N; Stewart T; Hearne P; Ping XY; Breshkin AM; Locarnini SA
    BMJ; 1995 Feb; 310(6975):285-8. PubMed ID: 7866168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS; Singh NB; Singh HL; Singh YM
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of hepatitis C incidence in Australian prisoners.
    Luciani F; Bretaña NA; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR;
    Addiction; 2014 Oct; 109(10):1695-706. PubMed ID: 24916002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.
    Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J;
    J Viral Hepat; 2017 Sep; 24(9):733-741. PubMed ID: 28256027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995.
    Crofts N; Aitken CK
    Med J Aust; 1997 Jul; 167(1):17-20. PubMed ID: 9236754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes.
    Vallejo F; Barrio G; Brugal MT; Pulido J; Toro C; Sordo L; Espelt A; Bravo MJ;
    J Epidemiol Community Health; 2015 Jun; 69(6):599-603. PubMed ID: 25870164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
    Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
    Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
    Maher L; Jalaludin B; Chant KG; Jayasuriya R; Sladden T; Kaldor JM; Sargent PL
    Addiction; 2006 Oct; 101(10):1499-508. PubMed ID: 16968352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.